Rallybio
Latest round
- Series B
Last raised
- Mar 2020
Total raised
- $182M
Investors
- 12
About Rallybio
Founded in 2018 and based in Connecticut, US, Rallybio, LLC is a biotechnology company that develops therapeutics for the treatment of different severe and rare diseases.2 million in 2020. Rallybio, LLC develops therapeutics and uses small molecule and protein-based therapies that help health professionals in identifying the necessary therapy for a certain disease. Its primary aim is to avoid prenatal and neonatal alloimmune thrombocytopenia, a potentially fatal uncommon condition that can cause uncontrollable bleeding in fetuses and infants. The company develops programs for various therapeutic areas like maternal fetal blood disorders, complement dysregulation and metabolic disorders. As of July 2021, Rallybio, LLC plans to become a public company under the ticker symbol RLYB on the Nasdaq.
Who invested in Rallybio
12 investors across 2 rounds
See all investors in Rallybio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rallybio
Who invested in Rallybio?
Rallybio has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rallybio raised?
Rallybio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Rallybio last raise money?
Rallybio's most recent round on record is a Series B, in Mar 2020.
What does Rallybio do?
Founded in 2018 and based in Connecticut, US, Rallybio, LLC is a biotechnology company that develops therapeutics for the treatment of different severe and rare diseases.
Where is Rallybio headquartered?
Rallybio is headquartered in New Haven, US.
Which VCs invest in companies like Rallybio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Rallybio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Rallybio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.